CIMCX
Price
$27.42
Change
-$0.00 (-0.00%)
Updated
Jul 13 closing price
Net Assets
145.28B
RAPCX
Price
$12.08
Change
+$0.06 (+0.50%)
Updated
Jul 13 closing price
Net Assets
1.91B
Interact to see
Advertisement

CIMCX vs RAPCX

CIMCX vs RAPCX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. RAPCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and RAPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 145B vs. RAPCX (1.91B). RAPCX pays higher dividends than CIMCX: RAPCX (4.95) vs CIMCX (2.73). CIMCX was incepted earlier than RAPCX: CIMCX (24 years) vs RAPCX (14 years). RAPCX (1.91) is less costly to investors than CIMCX (1.35). RAPCX is a more actively managed with annual turnover of: 76.00 vs. CIMCX (65.00). RAPCX has a lower initial minimum investment than CIMCX: RAPCX (0) vs CIMCX (250). RAPCX annual gain was more profitable for investors over the last year : 18.15 vs. CIMCX (5.96). RAPCX return over 5 years is better than : 36.70 vs. CIMCX (21.70).
CIMCXRAPCXCIMCX / RAPCX
Total Expense Ratio1.351.8175%
Annual Report Gross Expense Ratio1.351.9171%
Fund Existence24 years14 years-
Gain YTD6.48410.73960%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets145B1.91B7,608%
Annual Yield % from dividends2.734.9555%
Returns for 1 year5.9618.1533%
Returns for 3 years30.8135.6586%
Returns for 5 years21.7036.7059%
Returns for 10 years63.1272.8187%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NBIZ9.920.73
+7.94%
Tradr 2X Short Nbis Daily ETF
EQRR80.77N/A
N/A
ProShares Equities for Rising Rates ETF
CPSU27.68-0.02
-0.05%
Calamos S&P 500 Structured Alt Protection ETF - June
WTMF40.89-0.16
-0.39%
WisdomTree Managed Futures Strategy ETF
IHE99.99-0.52
-0.52%
iShares US Pharmaceuticals ETF